NLRP3 and familial dilated cardiomyopathy: Compared with the DCM group, the mRNA and protein levels of NLRP3 and related proteins (i.e., caspase-1, TXNIP, ASC, and IL-1β) were significantly reduced in the THJ treatment groups.